Atossa Therapeutics
ATOS
12 hedge funds and large institutions have $1.42M invested in Atossa Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
36% more capital invested
Capital invested by funds: $1.04M → $1.42M (+$377K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$72.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.9K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$29.9K |
| 4 |
FCCM
First City Capital Management
Savannah,
Georgia
|
+$29.9K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$55.4K |
| 2 |
Goldman Sachs
New York
|
-$38K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 4 |
Citigroup
New York
|
-$3K |
| 5 |
NPC
National Planning Corporation
El Segundo,
California
|
-$1.27K |
ATOS Hedge Fund Activity: Q1 2015 in Review
12 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Atossa Therapeutics (ATOS) for Q1 2015, worth a combined $1.42M — up 36% from $1.04M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATOS positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $72.5K. The largest seller was Virtu KCG Holdings, cutting an estimated $55.4K.
- 12 institutional investors held Atossa Therapeutics (ATOS) as of Q1 2015, up from 11 in Q4 2014.
- Funds reported $1.42M of Atossa Therapeutics stock for Q1 2015, up 36% quarter-over-quarter.
- 4 funds opened new Atossa Therapeutics positions in Q1 2015 and 3 closed out, a net change of +1 holder.
- The largest Atossa Therapeutics buyer in Q1 2015 was Millennium Management, an estimated $72.5K added.
- The largest Atossa Therapeutics seller in Q1 2015 was Virtu KCG Holdings, an estimated $55.4K sold.
Based on aggregated 13F filings for Q1 2015.